John Holmes to speak at MCA Annual Symposium
SARG Director Professor John Holmes will give a talk on no/lo drinks at the Medical Council on Alcohol's Annual Symposium this week (22.11.23).
His lecture will focus on the potential, pitfalls, and implications for public health policy of no- and low-alcohol drinks.
The rise of no/lo drinks
No- and low-alcohol (no/lo) drinks have become increasingly popular in recent years and now account for around one percent of total alcohol sales and two percent of off-trade beer sales. Further increases in no/lo sales could have a positive impact on public health by reducing alcohol consumption and the associated chronic health problems.
However, there are also concerns that people may consume no/lo drinks in addition to their usual alcoholic drinks, that companies may use alibi marketing to promote familiar alcohol brands, or that no/lo products may blur the distinction between drinking and non-drinking in harmful ways for high-risk groups.
The benefits or risks of no/lo drinks therefore depend on who purchases and consumes these products, the settings in which they consume them, and how that consumption relates to consumption of standard alcoholic drinks. Public health actors need to consider how they can contribute to developing a new policy framework that maximises any benefits of these products while minimising any risks.
The talk will draw on research being undertaken through the No/Lo Project which examines whether making non-alcoholic or low-alcohol drinks more common and popular in the UK can improve people's health.
About the symposium
The Medical Council on Alcohol's Annual Symposium is a key event for health professionals working to reduce alcohol-related health harms. The programme is aimed at clinicians and researchers across a variety of disciplines and specialties, highlighting both new research and policy and practical applications.
-
New SARG report details alcohol-related health and financial burden in Northern Ireland
The Sheffield Addictions Research Group (SARG) has published new analysis estimating the substantial health and financial toll of alcohol consumption in Northern Ireland, using the most recent available post-pandemic data.
-
New report reveals further growth and key trends in alcohol-free and low-alcohol drinks market
A second Monitoring Report from the Sheffield Addictions Research Group has been published, revealing further growth in the alcohol-free and low-alcohol (no/lo) drinks market and offering new insights into consumer behaviour and pricing.
-
SARG researchers to present at European nicotine and tobacco conference
Two researchers from the Sheffield Addictions Research Group (SARG), Esther Moore and Professor Hazel Squires, will present their latest findings at the annual conference of the European Chapter of the Society for Research on Nicotine and Tobacco (SRNT-E).
-
SARG researcher secures major Wellcome funding to model how context influences alcohol consumption
Dr Amber Copeland from the Sheffield Addictions Research Group (SARG) has been awarded a prestigious Wellcome Trust fellowship worth £591,755 over five years. The funding will support a new project to develop a cutting-edge computational model that explores how a person's environment influences their attempts to cut down on alcohol.
You might also be interested in…
-
New report reveals further growth and key trends in alcohol-free and low-alcohol drinks market
A second Monitoring Report from the Sheffield Addictions Research Group has been published, revealing further growth in the alcohol-free and low-alcohol (no/lo) drinks market and offering new insights into consumer behaviour and pricing.
-
SARG's Lucy Burke wins Open Research Prize 2025
Lucy Burke, a Qualitative Research Associate and PhD Student with the Sheffield Addictions Research Group (SARG), has been awarded the University of Sheffield Open Research Prize 2025 in the Postgraduate Researcher (PGR) category.
-
SARG showcases research at School of Medicine and Population Health event
Researchers from SARG are set to showcase their work at the University of Sheffield's School of Medicine and Population Health Research and Innovation Meeting 2025.